Guangxi Liuzhou Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
April 27, 2022 at 08:55 am EDT
Share
Guangxi Liuzhou Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 4,813.5 million compared to CNY 4,161.5 million a year ago. Revenue was CNY 4,813.5 million compared to CNY 4,161.5 million a year ago. Net income was CNY 220.95 million compared to CNY 207.75 million a year ago. Basic earnings per share from continuing operations was CNY 0.61 compared to CNY 0.57 a year ago. Diluted earnings per share from continuing operations was CNY 0.61 compared to CNY 0.57 a year ago.
Guangxi LiuYao Group Co Ltd, formerly Guangxi Liuzhou Pharmaceutical Co Ltd, is a China-based company mainly engaged in the sales of pharmaceuticals. The Company is mainly engaged in three businesses. The pharmaceutical wholesale business mainly distributes pharmaceutical products to medical and health institutions at all levels, pharmaceutical distribution enterprises and chain pharmacies. The pharmaceutical retail business provides sales and health services of various pharmaceutical products, medical devices and other pharmaceutical products to individual consumers through terminal pharmacies. The pharmaceutical industry business is mainly engaged in the production and processing of traditional Chinese medicine pieces and traditional Chinese medicine formula granules. The Company is also engaged in supply chain value-added services, pharmaceutical Internet services, terminal health services and others.